Filter posts

ICYMI – NYT: The Cost of Not Taking Your Medicine

We’ve long known that prescription medicines can yield substantial savings in other areas of healthcare …

Beyond the IPO: Reverse Mergers to Tap Public Market Capital

On the opening day of the 2017 BIO CEO & Investor Conference in New York …

Five Oncologists Weigh in on Value Frameworks

Value Frameworks, which attempt to quantify the value of a medicine, have been a hot …

What They’re Saying about the Medicare Part B Demo

Back in March, CMS’s Center for Medicare and Medicaid Innovation (CMMI) proposed a sweeping demonstration …

NORD President: Congress must act now to help 15 million sick children

Writing in The Hill, National Organization for Rare Disorders (NORD) President and CEO Peter Saltonstall …

Biotech Solutions for Zika

The Zika virus epidemic continues to rage on. Just today, the WHO advised people in Zika affected …

BIO Releases Largest Study Ever on Clinical Development Success Rates

On Wednesday, BIO released the largest ever study of clinical development success rates. The study, conducted in …

Morning Consult: Medicare’s Deadly Cancer Care Gamble

Today in Morning Consult, cancer survivor and health economist Jennifer Hinkel writes about the threat …

Report Finds Increasing Number of 340B Hospitals Provide Minimal Charity Care

A new report released yesterday by the Alliance for Integrity and Reform of 340B (AIR340B), …

Immune Deficiency Foundation: Medicare’s “one size fits all” drug demo is wrong for seniors wi...

Writing yesterday in The Hill, Immune Deficiency Foundation President Marcia Boyle explains the potential harm posed …